The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: A large study cohort from an academic medical center

American Journal of Clinical Pathology

Volumn 145, Issue 3, 2016, Pages 350-354

  Serdy, Kate ^a   Yildiz Aktas, Isil ^a   Li, Zaibo ^b   Zhao, Chengquan ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Early detection; Endometrial carcinoma; FIGO stage; Pap test

Indexed keywords

ADULT; AGED; CANCER PATIENT; CANCER STAGING; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; PAPANICOLAOU TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; CARCINOMA, ENDOMETRIOID; CLASSIFICATION; COHORT ANALYSIS; EARLY CANCER DIAGNOSIS; ENDOMETRIAL NEOPLASMS; MEDICAL EDUCATION; MISSOURI; PREDICTIVE VALUE; PROCEDURES; STANDARDS; UNIVERSITY HOSPITAL; VAGINA SMEAR; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; COHORT STUDIES; EARLY DETECTION OF CANCER; EDUCATION, MEDICAL, CONTINUING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MISSOURI; PAPANICOLAOU TEST; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; VAGINAL SMEARS;

EID: 84982161904     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1093/ajcp/aqv085     Document Type: Conference Paper

References (20)

1. Gu M, Shi W, Barakat RR, et al. Pap smears in women with endometrial carcinoma. Acta Cytol. 2001;45:555-560.
2. Sams SB, Currens HS, Raab SS. Liquid-based Papanicolaou tests in endometrial carcinoma diagnosis: performance, error root cause analysis, and quality improvement. Am J Clin Pathol. 2012;137:248-254.
3. Zhou J, Tomashefski J, Khiyami A. Diagnostic value of the thin-layer, liquid-based Pap test in endometrial cancer: a retrospective study with emphasis on cytomorphologic features. Acta Cytol. 2007;51:735-741.
4. Zhou J, Tomashefski JF, Khiyami A. ThinPrep Pap tests in patients with endometrial cancer: a histo-cytological correlation. Diagn Cytopathol. 2007;35:448-453.
5. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap test. Diagn Cytopathol. 2000;23:260-265.
6. Patel C, Ullal A, Roberts M, et al. Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology. Cytopathology. 2009;20:380-387.
7. Norimatsu Y, Shigematsu Y, Sakamoto S, et al. Nuclear characteristics of the endometrial cytology: liquid-based versus conventional preparation. Diagn Cytopathol. 2013;41:120-125.
8. Schorge JO, Hossein Saboorian M, Hynan L, et al. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer. 2002;96:338-343.
9. Zhao C, Li Z, Austin RM. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia. Am J Clin Pathol. 2013;140:47-54.
10. Zhou J, Tomashefski JF, Sawady J, et al. The diagnostic value of the ThinPrep Pap test in endometrial carcinoma: a prospective study with histological follow-up. Diagn Cytopathol. 2013;41:408-412.
11. Skaznik-Wikiel ME, Ueda SM, Frasure HE, et al. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol. 2011;55:255-260.
12. Pristauz G, Winter R, Fischerauer E, et al. Can routine gynecologic examination contribute to the diagnosis of cervical involvement by primary endometrial cancer? Eur J Gynaecol Oncol. 2009;30:497-499.
13. Zhao C, Florea A, Onisko A, et al. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114:383.
14. Shoji T, Takatori E, Takeuchi S, et al. Clinical significance of atypical glandular cells in the Bethesda system 2001: a comparison with the histopathological diagnosis of surgically resected specimens. Cancer Invest. 2014;32:105-109.
15. Tam KF, Cheung AN, Liu KL, et al. A retrospective review on atypical glandular cells of undetermined significance (AGUS) using the Bethesda 2001 classification. Gynecol Oncol. 2003;91:603-607.
16. Schnatz PF, Guile M, O'sullivan DM, et al. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006;107:701-708.
17. Desimone CP, Day ME, Tovar MM, et al. Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol. 2006;107:1285-1291.
18. Guy MS, Cheng G, Post MD, et al. Outcomes of women with atypical glandular cells on preoperative cytology and endometrial cancer. Int J Gynecol Cancer. 2014;24:266-271.
19. Li Z, Gilbert C, Yang H, et al. Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratory. Am J Clin Pathol. 2012;138:79-84.
20. Fadare O, Ghofrani M, Chacho MS, et al. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol. 2005;12:274-287.